{
  "pmcid": "6587743",
  "abstract": "250-word version:\n\nTitle: Randomised Controlled Trial of Biennial FOBT Screening for Colorectal Cancer\n\nBackground: This study aimed to evaluate the effects of biennial faecal occult blood test (FOBT) screening on colorectal cancer (CRC) outcomes beyond mortality and to explore potential sex differences in screening effectiveness.\n\nMethods: In a population-based randomised controlled trial conducted in Finland from 2004 to 2011, individuals aged 60â€“69 years were randomised 1:1 into screening and control arms. The primary outcome was CRC-specific mortality, with secondary outcomes including incidence, symptoms, tumour location, TNM categories, non-vital outcomes, and survival. Randomisation was stratified by birth year, sex, and residence. Outcome assessors were not blinded.\n\nResults: A total of 321,311 individuals were randomised, with 160,719 in the screening arm and 160,508 in the control arm. Analysis included 743 screening-detected and 617 control CRC cases. CRC was less common in women (0.34% vs. 0.50% in men; RR 0.82, 95% CI 0.74 to 0.91). Women more often had right-sided tumours (32.0% vs. 21.3% in men; RR 1.51, 95% CI 1.26 to 1.80). Among men with left-sided tumours, screening was associated with lower N and M categories and improved survival. No significant adverse events were reported.\n\nInterpretation: Biennial FOBT screening improved several outcomes in men but not in women, potentially due to differences in incidence, symptoms, and tumour location. Trial registration: Not provided. Funding: Not specified.",
  "word_count": 223
}